|
| 4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline Basic information |
| 4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline Chemical Properties |
Melting point | 105-107 °C | Boiling point | 446.7±45.0 °C(Predicted) | density | 1.257 | storage temp. | Keep in dark place,Sealed in dry,Room Temperature | solubility | DMSO: ≥20mg/mL | form | powder | pka | 0.54±0.30(Predicted) | color | white to off-white | InChI | InChI=1S/C14H17ClN2O4/c1-18-3-5-20-12-7-10-11(16-9-17-14(10)15)8-13(12)21-6-4-19-2/h7-9H,3-6H2,1-2H3 | InChIKey | ZPJLDMNVDPGZIU-UHFFFAOYSA-N | SMILES | N1=C2C(C=C(OCCOC)C(OCCOC)=C2)=C(Cl)N=C1 | CAS DataBase Reference | 183322-18-1(CAS DataBase Reference) |
Hazard Codes | Xn | Risk Statements | 22-41 | Safety Statements | 26-39 | WGK Germany | 3 | HS Code | 2933599590 |
| 4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline Usage And Synthesis |
Uses | 4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline is an aurora 2 kinase inhibitor, PDGF inhibitor, useful in the treatment of cancer. |
| 4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline Preparation Products And Raw materials |
|